View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Modality Solutions
26 September 2019

Modality Solutions Part of Inc 5000 List of America’s Fastest-Growing Companies

Biopharmaceutical cold chain engineering firm Modality Solutions is pleased to announce it ranked No 3094 on Inc Magazine’s annual Inc 5000 list, one of the most prestigious rankings of the nation’s fastest-growing private companies.

Modality Solutions reported a three-year revenue growth of 120%. Based on this growth, the Houston-based firm also ranked No. 47 in its industry category of top engineering companies.

Founded in 2011 by Gary Hutchinson and Daniel J Littlefield, Modality Solutions is a global biopharmaceutical cold chain engineering firm with regulatory filing authorities, logistics network expertise and process integration developers.

Established in 1982, the Inc 5000 list has become the hallmark of entrepreneurial success. In 2019, companies were ranked according to percentage revenue growth when comparing 2015 and 2018. To qualify, companies had to be US-based, privately held, for-profit and independent and have been founded and generating revenue by 31 March 2015. The minimum revenue required for 2015 was $100,000; the minimum for 2018 was $2 million.

According to Inc, not only have the companies on this year’s Inc 5000 been very competitive within their markets, but also the list shows staggering growth compared with prior lists. The 2019 Inc. 5000’s aggregate revenue was $237.7 billion in 2018, accounting for 1,216,308 jobs over the past three years.

“The companies on this year’s Inc. 5000 have followed so many different paths to success,” says Inc editor in chief James Ledbetter. “There’s no single course you can follow, or investment you can take that will guarantee this kind of spectacular growth. But what they have in common is persistence and seizing opportunities.

“Modality Solutions is pleased to gain recognition within the American economy’s most dynamic segment—its independent small businesses,” said President Gary Hutchinson. “Our primary goal is to continue to strive for excellence while we continue on our track of sustained growth. It’s great to join the ranks of companies like Microsoft, Dell, Pandora, Zillow, and many other well-known brands who gained their first national exposure as honourees on the Inc. 5000.”

In addition, in March 2019, Inc Magazine editors independently reviewed the Modality Solutions corporate information to initiate its participation in the Inc Verified Profile program. The editors independently reviewed the company to validate its website functionality and content, social media links, and phone lines to confirm Modality Solutions is fully operational. An Inc Verified Profile is meant to save prospective clients time by showcasing businesses that are part of a respected ecosystem of global entrepreneurs verified by Inc.

To view Modality Solutions Inc 5000 and Inc Verified Profile online page, or to find out more about Modality Solutions, please fill out the enquiry form attached to this page.

Competing priorities, changing expectations, cost pressures, sustainability initiatives, emerging markets - these are some of the challenges facing cold chain management professionals every day. Solutions...
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell...
Immunomedics (www.immunomedics.com) is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology